Gene · 5214
Papers1,761
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,761
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metagenomic Insights into Microbial Functional Potential Associated with Soil Carbon, Nitrogen, and Phosphorus Cycling Along an Elevational Gradient in a Warm-Temperate Forest. | Microorganisms | 2026 | 42795596 | PubTator, text mining | PubMed |
| Recombinant human SGK3 protein hydrogel: a novel therapeutic strategy for myocardial repair in ischemia/reperfusion injury. | Acta Biochim Biophys Sin (Shanghai) | 2026 | 42744988 | PubTator, text mining | PubMed |
| Transcriptomics and single-cell RNA sequencing uncover prognostic characteristics and immune regulatory mechanisms of lactylation in cervical cancer. | Bioimpacts | 2026 | 42666969 | PubTator, text mining | PubMed |
| Proteomics combined with single-cell sequencing reveals key genes and computational lead compound related to ligamentum flavum hypertrophy, lactate metabolism and lactate modification. | Biochem Biophys Res Commun | 2026 | 42632329 | PubTator, text mining | PubMed |
| Integrated analysis of enzymes, mRNAs, and miRNAs provides insight into the regulatory potential of extracellular vesicles in recipient cell glucose metabolism. | Front Bioinform | 2026 | 42630526 | PubTator, text mining | PubMed |
| Metabolic-epigenetic reprogramming via the PLOD1-PFKP axis drives cisplatin resistance in HNSCC. | Acta Pharm Sin B | 2026 | 42592154 | PubTator, text mining | PubMed |
| MFN2 inhibits colorectal cancer tumorigenesis by regulating glycolysis through TRIM21-mediated PFKP stability. | Mol Immunol | 2026 | 42541838 | PubTator, text mining | PubMed |
| Integrated multi-omics and SHAP analysis reveal the core mechanisms of metabolic reprogramming in lung adenocarcinoma. | Discov Oncol | 2026 | 42472421 | PubTator, text mining | PubMed |
| PFKP promotes oncogenesis in osteosarcoma through PI3K/HIF-1α pathway-mediated H3K18la modification. | Cell Signal | 2026 | 42425209 | PubTator, text mining | PubMed |
| PFKP: A biomarker for prognosis, response to treatment and immune function of breast cancer. | Int J Biol Markers | 2026 | 42394480 | PubTator, text mining | PubMed |
| Targeting phosphofructokinase in cancer: integrating natural products for metabolic reprogramming and therapeutic innovation. | Front Pharmacol | 2026 | 42358350 | PubTator, text mining | PubMed |
| Lactate as a Chemical Modification on Proteins and Metabolites. | Annu Rev Biochem | 2026 | 42331744 | PubTator, text mining | PubMed |
| Reciprocal regulation between JOSD2 and CREB1 drives aerobic glycolysis and progression of renal cell carcinoma. | Redox Biol | 2026 | 42308695 | PubTator, text mining | PubMed |
| Effects of trehalose, melatonin and lipid mixtures on bull sperm parameters and gene expressions during cryopreservation. | Cryobiology | 2026 | 42269524 | PubTator, text mining | PubMed |
| Investigation of the relationship between autophagy and Warburg effect in osteosarcoma cells: An in vitro study. | Cancer Treat Res Commun | 2026 | 42229266 | PubTator, text mining | PubMed |
| Hypoxia-driven HIF-1α-dependent glycolysis/lactate-associated signaling promotes autophagy-associated scleral remodeling in experimental myopia. | Exp Eye Res | 2026 | 42217725 | PubTator, text mining | PubMed |
| Prognostic significance of IDH1 promoter methylation and associated genome-wide alterations in breast cancer. | Sci Rep | 2026 | 42204197 | PubTator, text mining | PubMed |
| NEK6 Knockout Causes Defects in Mitochondrial Morphology and Respiration. | Cells | 2026 | 42193938 | PubTator, text mining | PubMed |
| Mitochondria-Associated mRNAs Restore ATP During Oxidative Stress via Cytosolic Translation. | Antioxidants (Basel) | 2026 | 42193202 | PubTator, text mining | PubMed |
| Single-cell and machine learning reveal ROS-associated heterogeneity in hepatocellular carcinoma for precision medicine. | BMC Cancer | 2026 | 42135662 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5214/papers